SCHEMBL4812845

SCHEMBL4812845

Cc1ccc(C(=O)OC2CCCC2(CCC(C)C)C(=O)OCC(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
PLA2G1B P04054 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
RAB9A P51151 3/20 0.34
ALDH1A1 P00352 3/20 0.34
NPC1 O15118 2/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 2/20 0.34
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
PTPN2 P17706 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4813285 0.94 PTPN2 (0.39) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4814193 0.92 ADRB2 (0.38) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4811054 0.91 TDP1 (0.38) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4812893 0.90 TRPM8 (0.38) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4811141 0.90 AKT1 (0.38) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4814085 0.89 ADRB2 (0.39) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4810949 0.89 ADRB2 (0.39) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4813337 0.89 AKT1 (0.42) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4813277 0.88 AKT1 (0.43) ADRB2ADRB1ADRB3SCN1ASCN2A
SCHEMBL4816351 0.88 ADRB2 (0.41) ADRB2ADRB1ADRB3RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388103-B2 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2008-06-17 US disclosed
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 US disclosed
WO-2006045246-A1 CYCLOPENTANE CARBOXYLATE COMPOUNDS, PROCESS AND INTERMEDIATES FOR PREPARING THE SAME AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof C5, C1S, AKR1C3 ADRB2 1572/4885ADRB1 1538/4885ADRB3 1177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.